Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

SEMERIN COUGH SYRUP

Approval Number

SIN03526P

Drug Name

SEMERIN COUGH SYRUP

Product Name

SEMERIN COUGH SYRUP

Approval Date

May 25, 1989

Registrant

CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

Licence Holder

CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

Regulatory Information

Registrant

CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

Licence Holder

CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

General Sale List

Formulation Information

Dosage Form

SYRUP

Route of Administration

ORAL

Medical Information

ATC Code

R05CA10

ATC Item Name

combinations

Manufacturer Information

Pharmaceutical Manufacturer

CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.

Manufacturers

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

Ingredient Name

SODIUM CITRATE

Strength

150 mg/5 ml

Drug MonographSodium citrate

Ingredient Name

EPHEDRINE HCl

Strength

4 mg/5 ml

Drug MonographEphedrine

Ingredient Name

AMMONIUM CHLORIDE

Strength

100 mg/5 ml

Drug MonographAmmonium chloride

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy